RAPTHealthcareMid-Cap

RAPT Therapeutics, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for RAPT Therapeutics, Inc. (RAPT), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are RAPT insiders buying or selling?

RAPT Therapeutics, Inc. insiders reported 30 open-market buys ($48.5M) and 92 sells ($82.0M) across 122 Form 4 filings — a net selling position of $33.5M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jan 8, 2024)

Total Form 4 filings
122
SEC EDGAR
Insider filers
12
Insider buys (30)
$48.5M
Insider sells (92)
$82.0M

Insider sentiment

Net selling

Net insider flow of $33.5M in net selling.

Recent RAPT insider transactions

DateInsiderRoleTypeSharesPriceValue
Jan 8, 2024Dirk G. BrockstedtCHIEF SCIENTIFIC OFFICERSale898$22.78$20.5K
Dec 22, 2023William HOChief Medical OfficerSale2.5K$21.68$54.2K
Nov 29, 2023William HOChief Medical OfficerSale1.5K$13.72$20.6K
Oct 4, 2023William HOChief Medical OfficerSale2.5K$15.77$39.4K
Aug 22, 2023William HOChief Medical OfficerSale2.5K$18.92$47.3K
Apr 20, 2023William HOChief Medical OfficerSale5.0K$18.88$94.4K
Mar 15, 2023Wendye RobbinsDirectorPurchase5.0K$19.52$97.6K
Mar 13, 2023William HOChief Medical OfficerSale5.0K$29.62$148.1K
Jan 26, 2023William HOChief Medical OfficerSale5.0K$30.00$150.0K
Jan 20, 2023William HOChief Medical OfficerSale5.0K$25.56$127.8K
Jan 9, 2023Dirk G. BrockstedtChief Scientific OfficerSale742$21.97$16.3K
Dec 30, 2022William HOChief Medical OfficerSale5.0K$18.03$90.2K
Nov 29, 2022William HOChief Medical OfficerSale5.0K$17.87$89.3K
Nov 3, 2022William HOChief Medical OfficerSale5.0K$22.32$111.6K
Oct 14, 2022William HOChief Medical OfficerSale2.0K$21.52$43.0K
Jul 13, 2022William HOChief Medical OfficerSale2.0K$19.95$39.9K
May 27, 2022COLUMN GROUP II, LP10% OwnerPurchase1.9K$12.45$23.7K
May 27, 2022Tim Kutzkey10% OwnerPurchase1.9K$12.45$23.7K
May 25, 2022COLUMN GROUP II, LP10% OwnerPurchase26.6K$12.19$323.7K
May 25, 2022Tim Kutzkey10% OwnerPurchase26.6K$12.19$323.7K
May 12, 2022COLUMN GROUP II, LP10% OwnerPurchase1.3M$10.67$13.3M
May 12, 2022Tim Kutzkey10% OwnerPurchase1.3M$10.67$13.3M
May 12, 2022Rodney KB YoungChief Financial OfficerPurchase5.0K$10.53$52.6K
May 5, 2022Dirk G. BrockstedtChief Scientific OfficerSale720$15.05$10.8K
Apr 12, 2022Dirk G. BrockstedtChief Scientific OfficerSale2.6K$23.05$61.0K

Showing the 25 most recent of 122 Form 4 filings for RAPT Therapeutics, Inc..

Most active RAPT insiders

  • William HO55 filings
  • Dirk G. Brockstedt22 filings
  • Wendye Robbins16 filings
  • Tim Kutzkey14 filings
  • Brian Russell Wong3 filings

Ask anything about RAPT insider activity

Use Trabud's AI agent to query RAPT Therapeutics, Inc.'s Form 4 history in plain English — "Show me RAPT CEO purchases this year" or compare it against any other ticker.

Open the AI agent

RAPT insider trading FAQ

Are RAPT Therapeutics, Inc. insiders buying or selling?

Across 122 SEC Form 4 filings, RAPT Therapeutics, Inc. (RAPT) insiders reported 30 open-market purchases totaling $48.5M and 92 sales totaling $82.0M. That is a net selling position of $33.5M.

How many insiders trade RAPT stock?

12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for RAPT Therapeutics, Inc.. The most recent filing was accepted on Jan 8, 2024.

Where does Trabud get RAPT insider trading data?

All RAPT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content